Skip to main content

Detect Impaired Gas Exchange Immediately

Transform cardiorespiratory data into actionable care

undefined - Imgur-1

What is the AGM100?

The MediPines AGM100 is the first of its kind, FDA Cleared, non-invasive pulmonary gas exchange analyzer. By providing instantaneous gas exchange measurements, physicians can assess and manage cardiorespiratory function of their patients much more accurately. The AGM100 measures critical parameters, such as blood and alveolar oxygen levels, with accuracy comparable to arterial blood gas (ABG) measurements; enabling faster clinical decision making and improved patient outcomes.

MediPines AGM100 Measurement Pointers

Why is Instant Gas Exchange Important?

Information on impaired gas exchange is key to gain more context on the patient's underlying condition. Having this information readily available enables physicians to make the most informed clinical decisions possible, eliminating doubt and uncertainty. 

Normal AGM100 Gas Exchange Measurement

 

Normal Gas Exchange

During steady-state breathing, a patient with no gas exchange impairment should exhibit a low Oxygen Deficit between 0-15 mmHg, which signifies little to no impairment between the alveolar oxygen level and the arterial blood oxygen level. In addition, normal CO2 levels (PETCO2) indicate adequte ventilation and high arterial blood oxygenation (gPaO2) indicate adequate oxygenation.

Abnormal AGM100 Gas Exchange Measurement

 

Abnormal Gas Exchange

Patients with moderate to severe respiratory impairment will display an elevated Oxygen Deficit (PAO2 - gPaO2), which indicates gas exchange impairment. Reduced CO2 levels (PETCO2) shows mild hypoventilation, with low arterial blood oxygenation (gPaO2) indicate moderate hypoxemia. This patient is hypoxic, likely due to a problem with V/Q mismatch or diffusion limitation.

Immediate Clarity for Informed Decisions

Get more context on your patient's true cardiorespiratory condition with gas exchange measurements. With immediate non-invasive results at the point of care, you spend less time waiting, and more time making decisions. Efficient diagnosis means more effective allocation of resources and earlier discharge for cardiorespiratory patients.

AGM® Gas Exchange Measurements

Symbol Description
Oxygen Deficit Gas exchange inefficiency (PAO2-gPaO2), mmHg
gPaO2 Calculated arterial partial pressure of oxygen, mmHg
PAO2 End-tidal oxygen partial pressure, mmHg
PETCO2 End-tidal carbon dioxide partial pressure, mmHg
gPaO2/ FiO2 Ratio of arterial partial pressure of oxygen to fraction of oxygen inspired
gPaO2/ PAO2 Arterial to alveolar partial pressure of oxygen exchange ratio
SpO2 Blood oxygen saturation, %
Respiratory Rate (RR) The number of breaths per minute
Pulse Rate (PR)
The number of heart beats per minute
RQ Respiratory quotient, ratio of carbon dioxide produced to oxygen used
PiO2 Partial pressure of inspired oxygen, mmHg
Pbar Barometric pressure, mmHg

 

Demonstrated Clinical Accuracy

Precision in cardiorespiratory assessment is vital, and the MediPines AGM100 achieves this with comparable accuracy to Arterial Blood Gas Analysis. This near 1:1 relationship guarantees accurate and dependable measurements for better patient outcomes.

abg agm100 comparison

What Physicians are Saying

left-quote Created with Sketch.

“An Oxygen Deficit of 40 mmHg or above predicted a need for supplemental oxygen at some point during that hospital course with, essentially, 99% accuracy. The area under the curve of the receiver operating characteristic curve was 0.99.​”

Medscape Emergency Medicine Interview

left-quote Created with Sketch.

"We're measuring these patients in the ER as a form of triage, to determine what kind of care we're going to provide. And then once the patient is admitted, we're monitoring these patients at least twice a day, to trend their responses to care and therapies. So far, its been extremely successful. We’re intervening much quicker to find out what it is that's going on, and then treating them..."  

Milwaukee Hospital Head of Respiratory

left-quote Created with Sketch.

"With AGM100 alone, I can manage her... I'm not depending on my clinical impression, I'm depending on objective science now. I have tests to guide my clinical suspicion."

Ascension Affiliated Pulmonologist

Use AGM100 to detect impairment

Identify the degree of respiratory impairment to improve clinical decision making

Frequently Asked Questions

Still have more? Feel free to reach out directly. 

What is Oxygen Deficit?
Oxygen Deficit is the difference between the oxygen concentration in the alveoli (PAO2) and the oxygen concentration in the arterial blood (gPaO2). It represents the degree of severity of impairment in gas exchange and can be analogous to a non-invasive A-a gradient. As Dr. John B. West states, "Oxygen Deficit is the most informative measure of gas exchange."
How compliant are patients with the AGM100 testing?
The AGM100 has a very a high patient compliance rate. Its non-invasive, pain-free, and easy-to-use design ensures that patients are comfortable and cooperative during testing, making it a reliable choice for frequent spot checks.
How difficult is it to test and interpret an AGM100 measurement?
Learning how to perform a test and interpret the results on the AGM100 takes less than an hour of training. The AGM100 parameters are all measurements that healthcare providers are already familiar with, making interpretation straightforward. 

Latest Articles from our Blog

Get the latest news on MediPines as we continue to advance respiratory medicine.

MediPines Announces New Reimbursement Code for Non-Invasive Assessment of Cardiorespiratory Status by the AGM100

New AMA CPT® Code Establishes Pathway For Clinicians To Submit Claims For Use Of MediPines AGM100®

MediPines Wins Prestigious Pediatric Medical Device Competition Focused on COVID-19-Related Technologies

MediPines, a respiratory medical device company, was selected a winner in the special COVID-19 edition of the "Make Your Medical Device Pitch for Kids!" competition presented by ...

UCSD Distinguished Lecture Series

UCSD John B. West Distinguished Lecture Series, Sponsored by MediPines, to Feature Nobel Laureate Dr. Gregg L. Semenza August 02, 2023 11:57 AM Eastern Daylight Time MediPines, ...

Medscape Interview Highlights MediPines AGM100’s 99% Accuracy for Emergency Room Oxygen Therapy Decisions in COVID-19 Patients

YORBA LINDA, Calif.–(BUSINESS WIRE)–In a video interview on “Hot Topics in Emergency Medicine” posted by Medscape, a group of emergency medicine experts and respiratory physiology ...

Medipines Featured in Los Angeles Business Journal

Innovative Technology Detects Respiratory Impairment Respiratory impairment detection has long been a diagnostic “blind spot,” with the traditional tools available causing ...

Emergency Department Study Demonstrates Utility of MediPines AGM100 in Triaging COVID-19 Patients

YORBA LINDA, Calif.–(BUSINESS WIRE)–In a study presented at the American Thoracic Society (ATS) International Conference 2022, the MediPines AGM100 was shown to provide data that ...

Physicians Use MediPines Non-Invasive Gas-Exchange Analyzer Technology to Assist with Differential Diagnosis for Pulmonary Embolism

YORBA LINDA, Calif., May 24, 2022–(BUSINESS WIRE)–An increasing number of physicians have been utilizing a unique gas exchange analyzer technology to enhance recognition and ...

MediPines Adds Three Global Thought Leaders to its Medical and Scientific Advisory Board

March 01, 2022 12:04 PM Eastern Standard Time YORBA LINDA, Calif.–(BUSINESS WIRE)–Orange County, California based MediPines Corporation, a market leader in the development of gas ...

World Health Organization Recognizes MediPines AGM100® in 2021 Compendium for Innovative Health Technologies

ORANGE COUNTY, Calif., Sept. 21, 2021 /CNW/ — The World Health Organization (WHO) has just featured MediPines AGM100®, pulmonary gas exchange analyzer as an innovative technology ...

MediPines AGM100® – Medical Design Excellence 2021 Award Winner

MediPines is pleased to announce that their AGM100® device has been awarded the prestigious Silver Award for Testing and Diagnostic Products in the 2021 Medical Design Excellence ...

MediPines AGM100® Gas Exchange Measurements Validated Against ABGs (Arterial Blood Gases)

Study Published in CHEST Validates MediPines AGM100® Non-invasive Pulmonary Gas Exchange Measurements with Arterial Blood Gases Under Hypoxic Conditions ORANGE COUNTY, Calif., May ...

MediPines Obtains International MDSAP ISO 13485 Medical Device Certification

ORANGE COUNTY, Calif., April 9, 2020 /PRNewswire/ — MediPines Corporation announces that it received the Medical Device Single Audit Program certification, MDSAP ISO 13485:2016 ...

FDA Cleared MediPines Gas Exchange Monitor Measures Freedivers’ Lung Efficiency in Ground-Breaking Study

Successful Study Findings Unveiled by University of British Columbia Researchers at International Conference in Orlando, Florida PR Newswire ORANGE COUNTY, Calif., April 12, 2019 ...

MediPines Announces FDA Clearance of Breakthrough Respiratory Device, the MediPines Gas Exchange Monitor

ORANGE COUNTY, Calif., Jan. 29, 2019 /PRNewswire/ — MediPines Corporation announced today it has received FDA 510(k) market clearance on its new non-invasive medical device, the ...